[MiR-300 Inhibits Invasion and Metastasis of Osteosarcoma Cell MG63 by Negatively Regulating PTTG1]

Overview

Journal Nan Fang Yi Ke Da Xue Xue Bao

Specialty General Medicine

Date 2021 Feb 24

PMID 33624604

Citations 3

Authors

D Liang

X Wu

J Bai

L Zhang

C Yin

W Zhong

Affiliations

Soon will be listed here.

Abstract

Objective: Overexpression of miR-300 can inhibit the invasion and metastasis of osteosarcoma cell MG63 by targeting PTTG1.

Citing Articles

Long-chain noncoding RNA LINC01569 upregulates filamin A-interacting protein 1-like to prevent metastasis of triple-negative breast cancer via sponging miR-300.

Jiang X, Lin J, Zhu Z Cancer Biomark. 2023; 39(2):79-94.

PMID: 37955081 PMC: 11002719. DOI: 10.3233/CBM-230261.

MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation.

Valacchi G, Pambianchi E, Coco S, Pulliero A, Izzotti A J Pers Med. 2022; 12(2).

PMID: 35207665 PMC: 8880698. DOI: 10.3390/jpm12020176.

MicroRNA-300 Inhibits the Proliferation and Metastasis of Cervical Cancer Cells via Posttranscriptional Suppression of G Protein-Coupled Receptor 34 (GPR34).

Wang M, Tian Y, Miao L, Zhao W J Oncol. 2021; 2021:2669822.

PMID: 34950207 PMC: 8691979. DOI: 10.1155/2021/2669822.

References

Meyers P, Schwartz C, Krailo M, Healey J, Bernstein M, Betcher D . Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. J Clin Oncol. 2008; 26(4):633-8. DOI: 10.1200/JCO.2008.14.0095. View

Wang Y, Hao F, Nan Y, Qu L, Na W, Jia C . PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis. Int J Biol Sci. 2018; 14(13):1883-1891. PMC: 6231221. DOI: 10.7150/ijbs.27854. View

Zou H, McGarry T, Bernal T, Kirschner M . Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science. 1999; 285(5426):418-22. DOI: 10.1126/science.285.5426.418. View

Tiram G, Segal E, Krivitsky A, Shreberk-Hassidim R, Ferber S, Ofek P . Identification of Dormancy-Associated MicroRNAs for the Design of Osteosarcoma-Targeted Dendritic Polyglycerol Nanopolyplexes. ACS Nano. 2016; 10(2):2028-45. DOI: 10.1021/acsnano.5b06189. View

Zhang Y, Huang S, Guo Y, Li L . MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R. Biomed Pharmacother. 2018; 106:1357-1363. DOI: 10.1016/j.biopha.2018.07.059. View

Lindsey B, Markel J, Kleinerman E . Osteosarcoma Overview. Rheumatol Ther. 2016; 4(1):25-43. PMC: 5443719. DOI: 10.1007/s40744-016-0050-2. View

Zhang B, Li H, Yin C, Sun X, Zheng S, Zhang C . Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31. Neuropathol Appl Neurobiol. 2016; 43(5):419-432. DOI: 10.1111/nan.12321. View

Zhao S, Li J, Feng J, Li Z, Liu Q, Lv P . Identification of Serum miRNA-423-5p Expression Signature in Somatotroph Adenomas. Int J Endocrinol. 2019; 2019:8516858. PMC: 6662485. DOI: 10.1155/2019/8516858. View

Yu J, Xie F, Bao X, Chen W, Xu Q . miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. Mol Cancer. 2014; 13:121. PMC: 4040483. DOI: 10.1186/1476-4598-13-121. View

10.

Marina N, Gebhardt M, Teot L, Gorlick R . Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004; 9(4):422-41. DOI: 10.1634/theoncologist.9-4-422. View

11.

He Y, Fang S, Bi Y, He T, Wang Y, Hong S . [Twist regulates proliferation, migration and invasion of osteosarcoma cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao. 2018; 38(5):554-560. PMC: 6743895. View

12.

Mellis D, Caporali A . MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target. Biochem Soc Trans. 2017; 46(1):11-21. DOI: 10.1042/BST20170037. View

13.

Lu T, Rothenberg M . MicroRNA. J Allergy Clin Immunol. 2017; 141(4):1202-1207. PMC: 5889965. DOI: 10.1016/j.jaci.2017.08.034. View

14.

Repo H, Gurvits N, Loyttyniemi E, Nykanen M, Lintunen M, Karra H . PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival. BMC Cancer. 2017; 17(1):705. PMC: 5658989. DOI: 10.1186/s12885-017-3694-6. View

15.

Caporali S, Alvino E, Levati L, Esposito A, Ciomei M, Brasca M . Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125. Biochem Pharmacol. 2012; 84(5):598-611. DOI: 10.1016/j.bcp.2012.06.004. View

16.

Hu Z, Zheng C, Su H, Zeng Y, Lin C, Guo Z . MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma. J Cell Biochem. 2018; 120(6):9964-9978. DOI: 10.1002/jcb.28279. View

17.

Malik M, Kakar S . Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2). Mol Cancer. 2006; 5:61. PMC: 1654177. DOI: 10.1186/1476-4598-5-61. View

18.

Liu Z, Chen S, Yang Y, Lu S, Zhao X, Hu B . miR-29a inhibits adhesion, migration, and invasion of osteosarcoma cells by suppressing CDC42. Int J Clin Exp Pathol. 2020; 12(11):4171-4180. PMC: 6949774. View

19.

He X, Gao Z, Xu H, Zhang Z, Fu P . A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes. J Orthop Surg Res. 2017; 12(1):5. PMC: 5237271. DOI: 10.1186/s13018-016-0500-0. View

20.

Jallepalli P, Waizenegger I, Bunz F, Langer S, Speicher M, Peters J . Securin is required for chromosomal stability in human cells. Cell. 2001; 105(4):445-57. DOI: 10.1016/s0092-8674(01)00340-3. View